samedan logo

 
 
spacer
home > pmps > winter 2008 > the future is disposable
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Future is Disposable

Christian Husegaard at Bang & Olufsen Medicom discusses how the market is now evolving towards more user-friendly injection systems, as evidenced by the emergence of next-generation, disposable auto injectors for various treatments

An increasing proportion of pipeline drugs and drug introductions are administered by injection. However, the development of corresponding injection devices has not been able to keep up with the development of these large molecule drug formulations, leaving an increasing number of patients to administer their own treatment by use of unwieldy and complicated devices.

THE GAP

The pharmaceutical biotechnology industry has contributed to the growth in injectable drugs, and is now a major driver in new drugs coming to the market. Despite the progress made in developing new and innovative treatments for a wide range of therapeutic areas, this does not appear to have been matched by the development in drug delivery solutions, creating a ‘quality gap’ between the two elements that should in practice be working together – the drug and the device.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.


spacer
Christian Husegaard is Vice President of Drug Delivery Solutions and Services at B&O Medicom. Having joined in 1995, he was appointed Vice President in 2007. Today Christian is working to develop and bring innovative and robust injection solutions to the market.
spacer
Christian Husegaard
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ACG Invests To Expand New Ultrasafe Line

In response to demand, ACG Films – one of the four businesses of ACG Group, the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical industry – has invested to expand its new series of ultra-high barrier blister films.
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement